Biosimilar Use in Breast Cancer Treatment: A National Survey of Brazilian Oncologists' Opinions, Practices, and Concerns

Biosimilar Use in Breast Cancer Treatment: A National Survey of Brazilian Oncologists' Opinions, Practices, and Concerns

PURPOSEBreast cancer is the most common malignancy in Brazilian women, with 66,280 new cases in 2020 (with 20% overexpressing human epidermal growth factor receptor 2 [HER2]). The trastuzumab biosimilar was the first oncology biosimilar approved in Brazil for HER2-positive breast cancer treatment. T...

Full description

Bibliographic Details
Main Authors:	Heloísa M. Resende, Leandro Ladislau, Ana Carolina F. Cardoso, Juliana Dinéia P. Brandão, Biazi R. Assis, Paola Cardoso, Pedro Henrique A. Marassi, Vivienne Castilho
Format:	Article
Language:	English
Published:	American Society of Clinical Oncology 2021-12-01
Series:	JCO Global Oncology
Online Access:	https://ascopubs.org/doi/10.1200/GO.20.00649

Similar Items

What do oncologists need to know about biosimilar products?
by: Linda K. S. Leung, et al.
Published: (2016-10-01)

Navigating adalimumab biosimilars: an expert opinion
by: Vered Abitbol, et al.
Published: (2023-10-01)

A RETROSPECTIVE EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF RITUXIMAB BIOSIMILAR (RTXM83) IN BRAZILIAN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
by: A.C.F. Cardoso, et al.
Published: (2020-11-01)

Sentinel lymph node biopsy using single-agent mapping tracer (blue dye) after neoadjuvant chemotherapy in a Brazilian cohort of breast cancer patients. Real world evidence
by: Heloisa Magda Resende, et al.
Published: (2021-07-01)

Side effects of Sorafenib and sunitinib: A new concern for dermatologist and oncologist
by: Prachi Gole, et al.
Published: (2014-01-01)

Opinião de uma amostra de reumatologistas brasileiros sobre biossimilares Opinion of some brazilian rheumatologists about biosimilars
by: Valderilio Feijó Azevedo, et al.
Published: (2011-12-01)

Commentary: Use of biosimilars for retinal diseases in India: Challenges and concerns
by: Aman Kumar, et al.
Published: (2021-01-01)

Advance care planning and goals of care discussion: the perspectives of Brazilian oncologists
by: Laiane Moraes Dias, et al.
Published: (2022-09-01)

The role of the oncologist
by: Tassone P, et al.
Published: (2010-05-01)

Excitement and Concerns of Young Radiation Oncologists over Automatic Segmentation: A French Perspective
by: Vincent Bourbonne, et al.
Published: (2023-03-01)

Second wave of COVID-19 – Not a matter of great concern for pediatric hematologist/oncologist
by: Minakshi Bansal, et al.
Published: (2022-06-01)

Assessing Oncologists’ Attitudes Concerning Comprehensive Genomic Profiling in Stage IV Lung Adenocarcinoma in Brazil
by: Aline F. Fares, MD, MSc, et al.
Published: (2022-10-01)

BIOSIMILARS IN INFLAMMATORY BOWEL DISEASES: an important moment for Brazilian gastroenterologists
by: Fábio Vieira TEIXEIRA, et al.
Published: (2015-03-01)

The Era of the Hepatic Oncologist
by: Ryosuke Tateishi
Published: (2020-06-01)

Geriatric assessment for oncologists
by: Beatriz Korc-Grodzicki, et al.
Published: (2015-12-01)

Metronomic Chemotherapy for Children in Low- and Middle-Income Countries: Survey of Current Practices and Opinions of Pediatric Oncologists
by: Gabriel Revon-Rivière, et al.
Published: (2019-07-01)

Biosimilars
by: Emel Bülbül Başkan
Published: (2022-04-01)

Biosimilar knowledge and viewpoints among Brazilian inflammatory bowel disease patients
by: Karoline Soares Garcia, et al.
Published: (2021-05-01)

Fluorouracil Bolus Use in Infusional Regimens Among Oncologists—A Survey by Brazilian Group of Gastrointestinal Tumors
by: Renata D. Peixoto, et al.
Published: (2021-12-01)

Estudos de medicamentos biosimilares Studies on biosimilar medications
by: Winston Bonetti Yoshida
Published: (2010-09-01)

Should oncologists trust cannabinoids?
by: Ioana Creanga-Murariu, et al.
Published: (2023-07-01)

Satisfaction of outpatient oncologists with their work
by: Liudmila Moskvicheva, et al.
Published: (2022-06-01)

MRI basics for radiation oncologists
by: Uulke A. van der Heide, et al.
Published: (2019-09-01)

Confession of a Pediatric Oncologist
by: Daniela Cristina Stefan
Published: (2017-04-01)

The Colombian Medical Oncologists Workforce
by: Raúl Murillo, et al.
Published: (2019-10-01)

Prescribing biosimilars
by: Aronson, J, et al.
Published: (2018)

BIOSIMILARS IN RHEUMATOLOGY
by: E. L. Nasonov
Published: (2017-01-01)

Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
by: Judith Steinberg, et al.
Published: (2019-05-01)

A National Survey of Medical Oncologist’s Opinions and Perceptions for Managing Rash Among mCRC Patients Treated with Panitumumab
by: Kimberly A. Lowe, et al.
Published: (2019-05-01)

Concepts and Challenges of Biosimilars in Breast Cancer: The Emergence of Trastuzumab Biosimilars
by: Alina Uifălean, et al.
Published: (2018-09-01)

Effect of Terminology Used to Describe Medical Oncologists on Perceptions of Radiation Oncologists as Equal Partners in Cancer Care
by: Malcolm D. Mattes, MD, et al.
Published: (2021-01-01)

The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC)
by: G.S. Fernandes, et al.
Published: (2018-01-01)

Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market
by: Morton Aaron Scheinberg, et al.

Nanotherapies from an oncologist doctor's view
by: Shuangqing Liu, et al.
Published: (2023-01-01)

Subungual melanoma in the practice of surgeon and oncologist
by: M. Y. Myasnyankin, et al.
Published: (2017-06-01)

Is an oncologist training reform long overdue?
by: K. Sh. Gantsev
Published: (2019-01-01)

A Call to action: For the attention of oncologists!
by: Abdul Ghafur Md
Published: (2012-07-01)

COVID-19 pandemic, superbugs, and the oncologists!
by: Abdul Ghafur
Published: (2021-01-01)

Basic MRI for the liver oncologists and surgeons
by: Vu LN, et al.
Published: (2018-04-01)

BRAZILIAN ORTHOPEDISTS' OPINIONS AND PERCEPTIONS ON FEMOROACETABULAR IMPINGEMENT
by: Leandro Ejnisman, et al.
Published: (2016-12-01)